Jessica Fees, See Remarks at Surface Oncology, Inc. (SURF), sold 1,500 shares at $11.19 ($17K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Scheduled sale ($17k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SURF | SELL | 2022-01-14 | $242K | — | Filing → |
| SURF | SELL | 2021-02-09 | $19K | — | Filing → |